Home » Newsletters » BioWorld

BioWorld

Oct. 10, 2001

View Archived Issues

Sequitur Enters Antisense Deal With P&G For Target Validation

Isis Rides Wave, Files To Sell 5M Shares In Public Offering

Yale Parasitologist Subverts Toxic Insects Dodgy Immune System To Engineer Therapeutic Strategies

Genome Therapeutics Acquires American Rights To Ramoplanin

Discovery Therapeutics Raises $45M For Clinical Development

Other News To Note

Correction

Cephalon Compiles Strong Data In Additional Provigil Indication